Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.36 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.35 |
| ▸ | HTR2A | P28223 | 4/20 | 0.35 |
| ▸ | HTR2C | P28335 | 4/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.35 |
| ▸ | HRH1 | P35367 | 4/20 | 0.35 |
| ▸ | HTR2B | P41595 | 4/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.35 |
| ▸ | DRD2 | P14416 | 3/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615807 | 1.00 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL20905279 | 0.86 | CYP11B1 (0.50) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL18596813 | 0.75 | CYP11B1 (0.42) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL13615993 | 0.75 | MEN1 (0.35) | LMNAMAPTMAPK1HTTSMN1; SMN2 | |
| SCHEMBL13615813 | 0.75 | MEN1 (0.35) | LMNAMAPTMAPK1HTTSMN1; SMN2 | |
| SCHEMBL20625222 | 0.74 | CYP11B1 (0.41) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL2604390 | 0.74 | MAOA (0.52) | CYP1A2HSD17B3SCN9AADRA2BADRA2C | |
| SCHEMBL13408726 | 0.73 | CYP11B1 (0.42) | CYP11B1CYP11B2CYP1A2HSD17B3SCN9A | |
| SCHEMBL20176571 | 0.72 | HSD17B3 (0.46) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL11978694 | 0.72 | NOTUM (0.44) | CYP1A2HSD17B3SCN9ASRD5A1ADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | CYP11B1 382/4885CYP11B2 470/4885CYP1A2 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.